恶性淋巴瘤中MTS1-p<sup>16</sup>基因的缺失

恶性淋巴瘤中MTS1-p¹⁶基因的缺失

摘要: 目的研究MTS1p¹⁶基因在恶性淋巴瘤中的变化。方法采用多重PCR 检测34 例非何杰金淋巴瘤（NHL）和15 例健康人体外周血DNA 的p¹⁶gene Exon2 纯合子缺失。结果 34 例NHL中有4 例有p¹⁶gene Exon2 纯合子缺失。结论 MTS1P¹⁶gene 变异可能在非何杰金淋巴瘤的发生发展中起作用。
- 非何杰金淋巴瘤 /
- MTS1-p¹⁶gene /
- 基因缺失
Abstract: Objective To investigate the alteration of MTS1/p 16 gene in lymphoma. Methods A total of 34 non-Hodgkin's lymphoma and 15 controls DNA specimens were examined for homozygous deletion of MTS1/p 16 gene Exon2 by Differential PCR. Results The results showed that 4 of 34 non-Hodgkin's lymphoma DNA specimens were found the deletion of MTS1/p 16 gene Exon2, with a 11 8%(4/34) MTS1/p 16 gene EXon2 deletion rate. Conclusion The results suggest that MTS1/p 16 gene alterations may play a role in the progression of non-Hodgkin's lymphoma.
- Non-Hodgkin's lymphoma /
- MTS1/p 16 gene /
- Gene deletion

[1]	傅松滨.多重肿瘤抑制基因MTS1/p16CDK4Ⅰ与细胞周期调节.国外医学遗传学分册，1996，19：6
[2]	J.萨姆布鲁克，E.F弗里奇，T.曼尼阿蒂斯著，金冬雁，黎孟枫，等译.分子克隆实验指南.第2版.北京：科学出版社，1996，465～467
[3]	Kamb A.Gruis NA.Feldhaus JW. et al. A cell cycle regulator potentially involved in genesis of many tumor tyges. Science, 1994,264:436
[4]	Gombart AF.Morosetti R,Miller CW, et al. Deletions of the cyclin-dependent kinase inhibitor genes p16 INK4A and p16 INK4B in non-Hodgkins lymphomas. Blood, 1995,86,1534
[5]	Ogawa S, Hangaishi A, Miyawaki S, et al. Loss of the cyclin dependent kinase 4 inhibitor (p16:MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Blood,1995,86:1548
[6]	Stranks G, Height S.E,Mitchell P, et al. Deletions and 　rearrangement of CDKN2 in lymphoid malignancy. Blood,1995,85:893